Why is Ajooni Biotech falling/rising?

As of 08-Sep, Ajooni Biotech Ltd is currently priced at Rs 5.22, reflecting a slight increase of Rs 0.01 or 0.19%. The stock has been trading lower than its moving averages across various time frames, indicating a bearish trend. Additionally, the stock is close to its 52-week low, being only 4.02% away from Rs 5.01. Despite a recent outperformance against its sector by 0.32%, the stock has shown a negative return of -1.69% over the past week and -1.51% over the past month. The company has reported positive results for the last four consecutive quarters, with net sales growing by 44.85% and profit after tax increasing by 67.58%. However, the stock's long-term fundamentals are weak, with a low return on capital employed and poor debt servicing ability, which may contribute to investor caution.
In the broader market context, Ajooni Biotech's recent performance is underwhelming compared to the benchmark Sensex, which has gained 0.60% over the past week and 1.68% over the past month. The stock has significantly underperformed the benchmark over the past year, with a staggering decline of -49.52% compared to the Sensex's slight drop of -0.32%. This stark contrast highlights the challenges Ajooni Biotech faces in regaining investor confidence, despite its attractive valuation metrics and recent profit growth. The falling investor participation, as evidenced by a 47.61% drop in delivery volume, further underscores the stock's struggle to attract buyers in a market that is otherwise showing resilience.